Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: Mechanism and substrate specificity

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 74, Issue 2, 2010, Pages 281-289

  Fischer, Wiebke ^a   Neubert, Reinhard H H ^a   Brandsch, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Biogenic amines; Caco 2 cells; Drug delivery; Intestinal epithelium; Membrane transport; Phenylethylamine (PEA)

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE; CARBON 14; CHLORPHENIRAMINE; CHOLINE; DIPHENHYDRAMINE; ETHYLAMINE; HARMALINE; METHADONE; N METHYLPHENETHYLAMINE; PHENELZINE; PHENETHYLAMINE; PROMETHAZINE; PROTON; SODIUM ION; TETRAMETHYLAMMONIUM; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

AMINE TRANSPORT; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BIOACCUMULATION; CELL PH; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME SPECIFICITY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; MEMBRANE TRANSPORT; TRANSPORT KINETICS;

BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; KINETICS; PHARMACEUTICAL PREPARATIONS; PHENETHYLAMINES; RADIOLIGAND ASSAY; SUBSTRATE SPECIFICITY;

EID: 75449103728     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.11.014     Document Type: Article

References (37)

1. Berry M.D. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J. Neurochem. 90 (2004) 257-271
2. Yang H.Y., and Neff N.H. β-Phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J. Pharmacol. Exp. Ther. 187 (1973) 365-371
3. Burchett S.A., and Hicks T.P. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog. Neurobiol. 79 (2006) 223-246
4. Zucchi R., Chiellini G., Scanlan T.S., and Grandy D.K. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 149 (2006) 967-978
5. Janssen P.A., Leysen J.E., Megens A.A., and Awouters F.H. Does phenylethylamine act as an endogenous amphetamine in some patients?. Int. J. Neuropsychopharmacol. 2 (1999) 229-240
6. Barak L.S., Salahpour A., Zhang X., Masri B., Sotnikova T.D., Ramsey A.J., Violin J.D., Lefkowitz R.J., Caron M.G., and Gainetdinov R.R. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol. Pharmacol. 74 (2008) 585-594
7. Frascarelli S., Ghelardoni S., Chiellini G., Vargiu R., Ronca-Testoni S., Scanlan T.S., Grandy D.K., and Zucchi R. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors. Eur. J. Pharmacol. 587 (2008) 231-236
8. Lindemann L., and Hoener M.C. A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol. Sci. 26 (2005) 274-281
9. Branchek T.A., and Blackburn T.P. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr. Opin. Pharmacol. 3 (2003) 90-97
10. Mason M., Wolf M.E., and Mosnaim A.D. Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytes. Comp. Biochem. Physiol. 76 (1983) 215-219
11. Da Prada M., Obrist R., and Pletscher A. Discrimination of monoamine uptake by membranes of adrenal chromaffin granules. Br. J. Pharmacol. 53 (1975) 257-265
12. Powers J.L., Plaskon R.R., Olsen G.A., and May S.W. Structural requirements for cocaine-sensitive and -insensitive uptake of phenethylamines into the adrenal chromaffin cell. J. Neurochem. 65 (1995) 2031-2042
13. Ben-Harari R.R., and Bakhle Y.S. Uptake of β-phenylethylamine in rat isolated lung. Biochem. Pharmacol. 29 (1980) 489-494
14. Kittams D.W., and Vidaver G.A. Inhibition by β-phenylethylamine and similar compounds of glycine transport by pigeon red cells. Biochim. Biophys. Acta 173 (1969) 540-547
15. Fischer W., Metzner L., Hoffmann K., Neubert R.H.H., and Brandsch M. Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells. Pharm. Res. 23 (2006) 131-137
16. Kuwayama K., Inoue H., Kanamori T., Tsujikawa K., Miyaguchi H., Iwata Y., Miyauchi S., Kamo N., and Kishi T. Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells. Biochim. Biophys. Acta 1778 (2008) 42-50
17. Marcobal A., de las Rivas B., and Muñoz R. First genetic characterization of a bacterial β-phenylethylamine biosynthetic enzyme in Enterococcus faecium RM58. FEMS Microbiol. Lett. 258 (2006) 144-149
18. Broadley K.J., Akhtar Anwar M., Herbert A.A., Fehler M., Jones E.M., Davies W.E., Kidd E.J., and Ford W.R. Effects of dietary amines on the gut and its vasculature. Br. J. Nutr. 19 (2008) 1-8
19. Koepsell H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci. 25 (2004) 375-381
20. Müller J., Lips K.S., Metzner L., Neubert R.H., Koepsell H., and Brandsch M. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem. Pharmacol. 70 (2005) 1851-1860
21. Fischer W., Praetor K., Metzner L., Neubert R.H.H., and Brandsch M. Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: mechanism and substrate specificity. Eur. J. Pharm. Biopharm. 70 (2008) 486-492
22. Knütter I., Hartrodt B., Theis S., Foltz M., Rastetter M., Daniel H., Neubert K., and Brandsch M. Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1. Eur. J. Pharm. Sci. 21 (2004) 61-67
23. +/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 16 (1999) 55-61
24. Liu J., Subir M., Nguyen K., and Eisenthal K.B. Second harmonic studies of ions crossing liposome membranes in real time. J. Phys. Chem. B 112 (2008) 15263-15266
25. Ling J., and Cashman J.R. N-oxygenation of phenethylamine to the trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes. J. Pharmacol. Exp. Ther. 282 (1997) 1269-1279
26. Ishida K., Takaai M., and Hashimoto Y. Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells. Biol. Pharm. Bull. 29 (2006) 522-526
27. Huwyler J., Fricker G., Torok M., Schneider M., and Drewe J. Transport of clonidine across cultured brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 282 (1997) 81-85
28. Fischer W., Neubert R.H.H., and Brandsch M. Clonidine accumulation in human neuronal cells. Eur. J. Pharm. Sci. 32 (2007) 291-295
29. Mizuuchi H., Katsura T., Saito H., Hashimoto Y., and Inui K.I. Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system. J. Pharmacol. Exp. Ther. 290 (1999) 388-392
30. Mizuuchi H., Katsura T., Ashida K., Hashimoto Y., and Inui K.I. Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000) G563-G569
31. +/tertiary amine antiport system in rabbit intestinal brush-border membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G799-G805
32. Han Y.H., Sweet D.H., Hu D.N., and Pritchard J.B. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. J. Pharmacol. Exp. Ther. 296 (2001) 450-457
33. Huebert N.D., Schuurmans Schwach V., Richter G., Zreika M., Hinze C., and Haegele K.D. The measurement of beta-phenylethylamine in human plasma and rat brain. Anal. Biochem. 221 (1994) 42-47
34. Okuda T., and Haga T. Functional characterization of the human high-affinity choline transporter. FEBS Lett. 484 (2000) 92-97
35. +-independent choline transporter in rat astrocytes. J. Neurochem. 94 (2005) 1427-1437
36. Otsuka M., Matsumoto T., Morimoto R., Arioka S., Omote H., and Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc. Natl. Acad. Sci. USA 102 (2005) 17923-17928
37. a, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives. Bioorg. Med. Chem. 14 (2006) 1715-1728